Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets.
Maxwell LJ, Jones C, Bingham CO, Boers M, Boonen A, Choy E, Christensen R, Conaghan PG, D'Agostino MA, Doria AS, Grosskleg S, Hill CL, Hofstetter C, Horgan B, Kroon F, Leung YY, Mackie S, Meara A, Shea BJ, Simon LS, Touma Z, Tugwell P, Wells GA, Beaton DE. Maxwell LJ, et al. Among authors: boers m. Semin Arthritis Rheum. 2024 Jun;66:152423. doi: 10.1016/j.semarthrit.2024.152423. Epub 2024 Feb 29. Semin Arthritis Rheum. 2024. PMID: 38460282
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
Berthelsen DB, Simon LS, Ioannidis JPA, Voshaar M, Richards P, Goel N, Strand V, Nielsen SM, Shea BJ, Tugwell P, Bartlett SJ, Hazlewood GS, March L, Singh JA, Suarez-Almazor ME, Boers M, Stevens RM, Furst DE, Woodworth T, Leong A, Brooks PM, Flurey C, Christensen R; OMERACT Safety Working Group. Berthelsen DB, et al. Among authors: boers m. Semin Arthritis Rheum. 2023 Dec;63:152288. doi: 10.1016/j.semarthrit.2023.152288. Epub 2023 Oct 26. Semin Arthritis Rheum. 2023. PMID: 37918049
Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative.
Weinbrecht-Mischkewitz M, Kamal M, Asim F, Guillemin F, Goel N, Voshaar M, Boonen A, Berthelsen DB, Toupin-April K, Lopez-Olivo MA, Sloan VS, Boers M, Jones CA, van der Horst-Bruinsma I, Cashin AG, Sharma S, Leong A, Alten R, Shea B, March L, Tugwell P, Christensen R, Nielsen SM; Contextual Factors Working Group. Weinbrecht-Mischkewitz M, et al. Among authors: boers m. Semin Arthritis Rheum. 2024 Apr;65:152370. doi: 10.1016/j.semarthrit.2024.152370. Epub 2024 Jan 10. Semin Arthritis Rheum. 2024. PMID: 38290371 Free article.
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set.
Lage-Hansen PR, Svendsen N, Kirkham J, Nielsen SM, Amris K, de Wit M, Boers M, Ellingsen T, Christensen R. Lage-Hansen PR, et al. Among authors: boers m. Ann Rheum Dis. 2024 May 22:ard-2024-225523. doi: 10.1136/ard-2024-225523. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38777377
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial.
Wagenaar CA, Walrabenstein W, van der Leeden M, Turkstra F, Gerritsen M, Twisk JWR, Boers M, van der Esch M, van Middendorp H, Weijs PJM, van Schaardenburg D. Wagenaar CA, et al. Among authors: boers m. RMD Open. 2024 Feb 27;10(1):e004025. doi: 10.1136/rmdopen-2023-004025. RMD Open. 2024. PMID: 38413171 Free PMC article.
620 results